Peregrine Ventures launches new $300 million fund to focus on late-stage life science companies
Peregrine Ventures launches new $300 million fund to focus on late-stage life science companies Peregrine Ventures, an Israeli venture capital firm today announced the launch of a new growth fund, Peregrine Growth, which focuses on late-stage life science companies. Peregrine closed $101 million of the planned $300 million fund, with participation of leading Israeli institutional […]
Continue Reading